Dai YN - Search Results

1

Aumento del nivel de betatrofina en suero en sujetos con síndrome metabólico: estudio de casos y controles.

Zhu JZ, Li CX, Dai YN, Zhao DJ, Fang ZY, Wan XY, Zhu HT, Wang YM, Yu CH, Li YM. Zhu JZ, et al. Among authors: dai yn. Nutr Hosp. 2016 Mar 25;33(2):108. doi: 10.20960/nh.108. Nutr Hosp. 2016. PMID: 27238790 Free article. Spanish.

2

Is Helicobacter pylori infection associated with glycemic control in diabetics?

Dai YN, Yu WL, Zhu HT, Ding JX, Yu CH, Li YM. Dai YN, et al. World J Gastroenterol. 2015 May 7;21(17):5407-16. doi: 10.3748/wjg.v21.i17.5407. World J Gastroenterol. 2015. PMID: 25954115 Free PMC article. Review.

3

Prevalence of fatty liver disease and the economy in China: A systematic review.

Zhu JZ, Zhou QY, Wang YM, Dai YN, Zhu J, Yu CH, Li YM. Zhu JZ, et al. Among authors: dai yn. World J Gastroenterol. 2015 May 14;21(18):5695-706. doi: 10.3748/wjg.v21.i18.5695. World J Gastroenterol. 2015. PMID: 25987797 Free PMC article. Review.

4

Prevalence of Nonalcoholic Fatty Liver Disease and Economy.

Zhu JZ, Dai YN, Wang YM, Zhou QY, Yu CH, Li YM. Zhu JZ, et al. Among authors: dai yn. Dig Dis Sci. 2015 Nov;60(11):3194-202. doi: 10.1007/s10620-015-3728-3. Epub 2015 May 28. Dig Dis Sci. 2015. PMID: 26017679 Review.

5

Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis.

Dai YN, Wang JH, Zhu JZ, Lin JQ, Yu CH, Li YM. Dai YN, et al. Cancer Causes Control. 2015 Sep;26(9):1245-55. doi: 10.1007/s10552-015-0617-1. Epub 2015 Jun 17. Cancer Causes Control. 2015. PMID: 26081426 Review.

6

Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study.

Zhu JZ, Zhu HT, Dai YN, Li CX, Fang ZY, Zhao DJ, Wan XY, Wang YM, Wang F, Yu CH, Li YM. Zhu JZ, et al. Among authors: dai yn. Endocrine. 2016 Jan;51(1):91-100. doi: 10.1007/s12020-015-0735-2. Epub 2015 Sep 11. Endocrine. 2016. PMID: 26362060

7

A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease.

Dai YN, Zhu JZ, Fang ZY, Zhao DJ, Wan XY, Zhu HT, Yu CH, Li YM. Dai YN, et al. Metabolism. 2015 Dec;64(12):1667-73. doi: 10.1016/j.metabol.2015.08.013. Epub 2015 Aug 28. Metabolism. 2015. PMID: 26476959

8

Association of homocysteine level with biopsy-proven non-alcoholic fatty liver disease: a meta-analysis.

Dai Y, Zhu J, Meng D, Yu C, Li Y. Dai Y, et al. J Clin Biochem Nutr. 2016 Jan;58(1):76-83. doi: 10.3164/jcbn.15-54. Epub 2015 Aug 29. J Clin Biochem Nutr. 2016. PMID: 26798201 Free PMC article.

9

Confocal laser endomicroscopy reveals alterations in duodenal permeability in patients with acute pancreatitis.

Sun L, Yue M, Dai Y, Yu C, Chen C. Sun L, et al. J Int Med Res. 2019 Mar;47(3):1279-1287. doi: 10.1177/0300060518820430. J Int Med Res. 2019. PMID: 32516018 Free PMC article.

10

Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease.

Dai YN, Xu CF, Pan HY, Huang HJ, Chen MJ, Li YM, Yu CH. Dai YN, et al. World J Clin Cases. 2022 May 6;10(13):4097-4109. doi: 10.12998/wjcc.v10.i13.4097. World J Clin Cases. 2022. PMID: 35665109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters